Edward Barias, MD
Addiction Psychiatry · Jupiter, FLNPI 1689007700
Payments from drug & device makers
Across 868 payments — averaging $23.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Otsuka America Pharmaceutical, Inc.$2K
- Alkermes, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$1K
- plus $7K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 212 | $6,357 |
| Otsuka America Pharmaceutical, Inc. | 65 | $1,859 |
| Alkermes, Inc. | 71 | $1,569 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 65 | $1,539 |
| Takeda Pharmaceuticals U.S.A., Inc. | 92 | $1,294 |
| Johnson & Johnson | 54 | $1,140 |
| Neurocrine Biosciences, Inc. | 39 | $1,105 |
| Corium, LLC | 29 | $709 |
| Teva Pharmaceuticals USA, Inc. | 34 | $675 |
| Lundbeck LLC | 39 | $595 |
| Indivior Inc. | 22 | $565 |
| Axsome Therapeutics, Inc. | 15 | $429 |
| Livanova USA, Inc. | 9 | $381 |
| Sunovion Pharmaceuticals Inc. | 20 | $373 |
| Eisai Inc. | 6 | $313 |
| Vanda Pharmaceuticals Inc. | 15 | $294 |
| E.r. Squibb & Sons, L.L.C. | 15 | $270 |
| Tris Pharma Inc | 10 | $204 |
| Idorsia Pharmaceuticals US Inc | 10 | $198 |
| Bausch Health US, LLC | 10 | $176 |
| Supernus Pharmaceuticals, Inc. | 8 | $166 |
| Almatica Pharma LLC | 7 | $149 |
| Braeburn Inc. | 5 | $125 |
| Alfasigma USA, Inc. | 5 | $114 |
| Noven Therapeutics, LLC | 2 | $47 |
| Neuronetics, Inc. | 2 | $41 |
| Merck | 2 | $28 |
| Biogen | 1 | $27 |
| Brainsway USA Inc | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $9 |
How this compares
$20,793 in reported general payments places this provider in the 85th percentile of 29 addiction psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other addiction psychiatry in Jupiter
- Zaheer AslamFort Myers$1.8M
- Julio Castro GayolPalmetto Bay$442K
- Raul RodriguezDelray Beach$99K
- Jason FieldsNew Port Richey$26K
- Mary SheehanTampa$16K
- Aldo MoralesFort Lauderdale$13K
- Krishan BatraOdessa$10K
- Lawrence WeinsteinSt Petersburg$6K
- Syed ZaidiPinellas Park$5K
- Vincence DillonPensacola$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.